Publicaciones en las que colabora con Esperanza Naredo Sánchez (18)

2022

  1. Inmune-mediated inflammatory rheumatic diseases in transgender people: A scoping review

    Seminars in Arthritis and Rheumatism, Vol. 52

  2. Intra-articular therapies: patient preferences and professional practices in European countries

    Rheumatology International, Vol. 42, Núm. 5, pp. 869-878

2021

  1. EULAR recommendations for intra-articular therapies

    Annals of the Rheumatic Diseases, Vol. 80, Núm. 10, pp. 1299-1305

  2. EULAR recommendations for the reporting of ultrasound studies in rheumatic and musculoskeletal diseases (RMDs)

    Annals of the Rheumatic Diseases, Vol. 80, Núm. 7, pp. 840-847

  3. Efficacy and safety of intra-articular therapies in rheumatic and musculoskeletal diseases: An overview of systematic reviews

    RMD Open, Vol. 7, Núm. 2

  4. Safety in the use of ultrasound in rheumatology during the COVID-19 Pandemic. Spanish Society of Rheumatology positioning paper

    Reumatologia Clinica, Vol. 17, Núm. 5, pp. 284-289

2020

  1. Clinical, Patient-Reported, and Ultrasound Outcomes from an Open-Label, 12-week Observational Study of Certolizumab Pegol in Spanish Patients with Rheumatoid Arthritis with or without Prior Anti-TNF Exposure

    Reumatologia Clinica, Vol. 16, Núm. 5, pp. 345-352

2017

  1. Exploring the remission concept in rheumatoid arthritis with patients and rheumatologists: Time for a new approach?

    Clinical and Experimental Rheumatology, Vol. 35, Núm. 5, pp. 816-822

  2. Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project

    Journal of Clinical Lipidology, Vol. 11, Núm. 3, pp. 749-756.e3

  3. The 2017 EULAR standardised procedures for ultrasound imaging in rheumatology

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 12, pp. 1974-1979

2015

  1. Erratum to "Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project" [Semin Arthritis Rheum 44 (2015) 618-626]

    Seminars in Arthritis and Rheumatism

2012

  1. Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versus switching to rituximab in patients with rheumatoid arthritis who failed previous TNF antagonists: The MIRAR Study

    Annals of the Rheumatic Diseases, Vol. 71, Núm. 11, pp. 1861-1864

2011

  1. Enseñanza de ecografía en la reumatología española: 15 años de experiencia

    Reumatologia Clinica, Vol. 7, Núm. 6, pp. 354-356

2010

  1. Power doppler ultrasonography assessment of entheses in spondyloarthropathies: Response to therapy of entheseal abnormalities

    Journal of Rheumatology, Vol. 37, Núm. 10, pp. 2110-2117

2008

  1. Power doppler ultrasonographic monitoring of response to anti-tumor necrosis factor therapy in patients with rheumatoid arthritis

    Arthritis and Rheumatism, Vol. 58, Núm. 8, pp. 2248-2256

2007

  1. Longitudinal power Doppler ultrasonographic assessment of joint inflammatory activity in early rheumatoid arthritis: Predictive value in disease activity and radiologic progression

    Arthritis Care and Research, Vol. 57, Núm. 1, pp. 116-124

2005

  1. Assessment of inflammatory activity in rheumatoid arthritis: A comparative study of clinical evaluation with grey scale and power Doppler ultrasonography

    Annals of the Rheumatic Diseases, Vol. 64, Núm. 3, pp. 375-381

  2. Ultrasonographic assessment of inflammatory activity in rhematoid arthritis: Comparison of extended versus reduced joint evaluation

    Clinical and Experimental Rheumatology, Vol. 23, Núm. 6, pp. 881-884